from the transgenic reporter expression assays raise pression of CD8, both in thymus-derived T cells and in IELs, and had no thymic developmental alterations. This the question of why so many different cis-acting elements are required for the regulation of CD8 expression.
indicated that other regulatory elements at the CD8 locus are sufficient to direct normal expression of CD8 in To investigate whether different elements have unique regulatory functions, we and others have begun a systhe absence of E8 II (CIV-4,5). Since in transgenic mice both E8 I (CIII-1,2) and E8 II (CIV-4,5) direct expression in tematic deletional analysis of enhancers in the mouse germ line (Ellmeier et al., 1998; Hostert et al., 1998). mature CD8 ϩ T cells, we generated E8 I (CIII-1,2)/E8 II (CIV-4,5) double-deficient mice (⌬1⌬2/⌬1⌬2 mice) to test The generation of E8 I (CIII-1,2)-deficient (⌬1/⌬1) mice revealed that E8 I (CIII-1,2) is the major cis-regulatory whether these two enhancers are able to compensate for each other. In contrast to individual deletions, deleelement that directs CD8␣ expression in extrathymically derived IELs. In contrast, thymic-derived T cell lineages tion of both enhancers had a major effect on the expression of CD8 during thymocyte development but not in from these mutant mice displayed a normal expression pattern of CD8, indicating that other elements are able mature CD8 lineage cells. A population of "CD8-negative" SP thymocytes appeared that was indistinguishto compensate for loss of E8 I (CIII-1,2).
In this study, we have focused on enhancer E8 II (CIVable from DP thymocytes by analysis of other surface markers and by functional phenotype. The emergence 4,5), which was shown to have activity in DP and CD8 SP thymocytes and in mature CD8 ϩ T cells (Ellmeier et of this subset of cells indicated that CD8 expression is variegated in DP thymocytes of ⌬1⌬2/⌬1⌬2 mice. Sural., 1998). We wished to determine whether the E8 II (CIV-4,5) activity observed in transgenic mice reflects a prisingly, expression of CD8 on DP cells from ⌬1⌬2/ ⌬1⌬2 mice was at a level similar to that from wild-type unique and nonredundant function of this enhancer in the regulation of CD8␣ and CD8␤ gene expression durlittermates. These results reveal a previously unexpected function of two distinct enhancer elements, suging the development of thymic-derived T cells. We found that E8 II (CIV-4,5)-deficient (⌬2/⌬2) mice had normal exgest that additional enhancers contribute to the initiation (Sleckman et al., 1996) . This genthe deletion of E8 II (CIV-4,5) had no effect on the thymic ( Figure 2A ) or peripheral expression of CD8 ( Figure 2B T cell development or on the expression of CD8 in thymus-derived T cells. In contrast, thymocytes from douand Table 1 ). Furthermore, T cell development was normal and there was no difference in the relative abunble-deficient mice displayed a dramatic change in the CD4 versus CD8 expression profile ( Figures 3A and 3C) . dance of the different T cell subsets compared to wildtype mice ( Figure 2C and data not shown). In addition, An increase in CD4 SP thymocytes was observed (from 11% to 29%), while the percentage of DP thymocytes the expression of CD8␣␣ homodimers on IEL was similar in wild-type and ⌬2/⌬2 mice ( Figure 6B ). decreased (from 84% to 65%). In addition, the percentage (from 4.5% to 1.8%; Figure 3C ) and also the absolute Generation of ⌬1⌬2/⌬1⌬2 Mice numbers (from 2.8 Ϯ 0.2 ϫ 10 6 in ϩ/⌬1⌬2 mice to 1.9 Ϯ The results from the analysis of ⌬2/⌬2 mice clearly indi-0.2 ϫ 10 6 in ⌬1⌬2/⌬1⌬2 littermates; n ϭ 3 and 4, respeccated that other regulatory elements were able to comtively) of CD8 SP thymocytes in the thymus of ⌬1⌬2/ pensate for loss of E8 II (CIV-4,5) enhancer activity. Other ⌬1⌬2 mice were decreased. However, the total number enhancers such as the mature CD8 enhancer E8 I (CIIIof thymocytes in ϩ/⌬1⌬2 and ⌬1⌬2/⌬1⌬2 mice was not 1,2) or the DP-specific enhancer E8 (Table 1) . Furthermore, all E8 II (CIV-4,5) and E8 I (CIII-1,2) have redundant functions CD8-expressing thymocytes and T cells expressed both in the regulation of CD8␣ and CD8␤ gene expression, CD8␣ and CD8␤ ( Figure 4E and data not shown). we generated mice lacking both enhancers. Therefore, ϩ/⌬2 ES cells were transfected with the E8 I (CIII-"CD8-Negative" SP Thymocytes in ⌬1⌬2/⌬1⌬2 Mice 1,2) targeting construct (Ellmeier et al., 1998), and E8 I
The increase in the percentage of CD4 SP thymocytes (CIII-1,2)-targeted ϩ/⌬2 ES cells were subsequently could be explained by at least three mechanisms. It screened by Southern blotting to identify ES cells that could be caused either by a loss of CD8 expression on had both enhancers deleted at the same CD8 locus DP thymocytes, by an increase in positive selection of allele. Heterozygous ϩ/N1⌬2 ES cells were then injected CD4 lineage cells, or even by a developmental switch into C57Bl/6 blastocysts, and subsequently ϩ/N1⌬2 from the CD8 to CD4 T cell lineage caused by alterations mice were obtained. To delete the neomycin expression in the expression of CD8. To investigate whether one cassette, ϩ/N1⌬2 mice were crossed with transgenic of these mechanisms was responsible for the altered mice expressing Cre recombinase under the control of thymic profile in ⌬1⌬2/⌬1⌬2 mice, we determined the the CMV promoter (White et al., 1997). Heterozygous developmental stage of the CD4 SP cells by examining ϩ/⌬1⌬2 mice were then interbred to obtain ϩ/ϩ, ϩ/ the expression of CD3, HSA, CD69, and CD5. As pre-⌬1⌬2, and ⌬1⌬2/⌬1⌬2 mice [see Figure 1D for 
/⌬1⌬2
C57Bl/6 mice, thus showing that "CD8-negative" SP thymocytes express neither CD8␣ nor alterations in CD8 expression occurred at early stages (i.e., before positive selection) of T cell development.
CD8␤. To functionally test whether the "CD8-negative" SP thymocytes are indeed DP thymocytes that do not exVariegated Expression of CD8 in ⌬1⌬2/⌬1⌬2 DP Thymocytes press CD8, their sensitivity toward glucocorticoids was determined. Dexamethasone injection caused the disFollowing ␤ selection and proliferation of double-negative stage 3 (DN3) thymocytes, CD8 and CD4 are exappearance of both DP and "CD8-negative" SP thymocytes after 48 hr but had no effect on CD4 SP cells in pressed and the cells progress to the DP stage. To follow the development of "CD8-negative" SP thymocytes and control mice ( Figure 4D ). In addition, "CD8-negative" SP thymocytes and DP thymocytes from mutant mice DP thymocytes in ⌬1⌬2/⌬1⌬2 mice, fetal thymic organ culture (FTOC) experiments were performed. E14.5 thydisplayed similar proliferative profiles in short-term BrdU labeling experiments (data not shown). mic lobes from ϩ/⌬1⌬2 and ⌬1⌬2/⌬1⌬2 mice were isolated and cultured, and the appearance of cells expressWe also wished to determine whether "CD8-negative" SP thymocytes express CD8␤ (which requires CD8␣ for ing CD4 and CD8 was monitored over a period of several days. The vast majority of ϩ/⌬1⌬2 and ⌬1⌬2/⌬1⌬2 thysurface expression). To test for the expression of CD8␤, ble-deficient (⌬1⌬2/⌬1⌬2) mice and showed that these two enhancers function together in an unexpected manner in the establishment of CD8 expression in immature mocytes were still at the DN stage after 1 day in culture (Figure 5 ), although some immature CD8 SP (ISP) thymothymocytes. Single or double mutations had little effect on CD8 expression in mature CD8 lineage T cells, and cytes were detected. After 3 days, a high percentage of ISP and DP thymocytes but only few CD4 SP cells were single mutations also had no effect on expression of CD8 in thymocytes. However, deletion of both enhancers led present in the ϩ/⌬1⌬2 culture. In the ⌬1⌬2/⌬1⌬2 culture, DP thymocytes and ISP were also present. However, to the appearance of "CD8-negative" SP thymocytes that, by several criteria, were shown to be DP thymothere was an increase in the percentage of "CD8-negative" SP thymocytes, and therefore the ratio of CD4 SP cytes that do not express CD8. The concurrent appearance of "CD8-negative" SP thymocytes and DP cells is to DP cells was much higher than in the ϩ/⌬1⌬2 culture. In addition, a decrease in the percentage of immature consistent with variegation of expression of CD8 in ⌬1⌬2/⌬1⌬2 DP thymocytes, which suggests that precur-CD8 SP ⌬1⌬2/⌬1⌬2 thymocytes was observed. The emergence of "CD8-negative" SP thymocytes in ⌬1⌬2/ sor cells in mutant mice undergo stochastic establishment or loss of CD8 gene expression. As a consequence, ⌬1⌬2 cultures was even more pronounced after 7 days. ϩ T cells tive selection. but also in developing thymocytes. Since other enAn explanation for the appearance of the "CD8-negahancers such as the mature CD8 enhancer E8 I (CIII-1,2) tive" SP cells that we cannot exclude at the present or the DP-specific enhancer E8 III (CIV-3) are able to direct time is that there are at least two distinct subsets of DP expression in similar T cell subsets as E8 II (CIV-4,5) short-term BrdU labeling studies in mice showed that Thus, although transgenic analysis of reporter genes both "CD8-negative" SP cells and DP thymocytes incorhas suggested that enhancers may function in sequenporated BrdU to a similar extent. Thus, the enhancer tial stage-specific activation of the locus, the results switching model insufficiently explains the presence of presented here suggest a more complex mechanism. "CD8-negative" SP thymocytes in ⌬1⌬2/⌬1⌬2 thymo-E8 I (CIII-1,2) appears to contribute to establishment of cytes.
CD8 expression in immature thymocytes even though
We favor an alternative explanation to describe the it fails to direct expression of reporter genes in thymus; phenotype of ⌬1⌬2/⌬1⌬2 mice, which is that E8 I (CIIIsimilarly, E8 II (CIV-4,5) contributes to expression in IEL 1,2) and E8 II (CIV-4,5) are involved in the initiation of that is only revealed by analysis of mice with compound CD8 expression in DN thymocytes. 
